SPDR S&P Biotech ETF (XBI)
Description
The investment seeks to track the performance of the S&P Biotechnology Select Industry Index. The XBI ETF contains 196 constituents. It is focused on growth holdings in the North America region.
Price $76.72 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | |
| Expense ratio | 0.35% |
| Average spread | 0.039% |
| 1Y roundtrip cost | 0.389% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -16.6% | -3.9% | 0.1% | -17.9% | -6.8% | 8.0% | 9.2% | 3.2% | -5.2% | -3.3% | -33.2% | ||
| 2021 | 8.6% | -3.2% | -8.3% | 0.7% | -6.2% | 5.7% | -8.9% | 7.6% | -5.4% | -0.7% | -6.8% | -3.7% | -20.6% |
| 2020 | -6.3% | 0.1% | -13.2% | 20.6% | 10.9% | 8.1% | -2.3% | 2.3% | -0.3% | 1.2% | 18.1% | 5.8% | 45.0% |
| 2019 | 16.5% | 6.6% | 1.6% | -5.9% | -6.8% | 10.4% | -2.3% | -6.2% | -5.1% | 7.1% | 14.7% | 1.6% | 32.2% |
| 2018 | 10.0% | -3.2% | -2.8% | -0.9% | 8.8% | 0.6% | 0.1% | 5.1% | -4.2% | -17.5% | 3.2% | -12.1% | -12.8% |
| 2017 | 9.6% | 8.2% | -1.2% | 3.0% | -5.2% | 14.2% | 1.3% | 7.2% | 3.3% | -3.4% | -0.5% | 2.1% | 38.6% |
| 2016 | -28.0% | -5.2% | 8.0% | 4.4% | 7.6% | -6.8% | 14.8% | -3.2% | 10.4% | -15.3% | 11.6% | -5.5% | -7.2% |
| 2015 | 7.1% | 7.5% | 5.2% | -8.5% | 15.4% | 6.1% | 1.3% | -13.1% | -15.9% | 7.0% | 8.5% | -2.7% | 18.0% |
| 2014 | 15.4% | 9.0% | -12.8% | -9.7% | 2.8% | 16.9% | -5.1% | 10.8% | -3.4% | 9.9% | 4.9% | 4.0% | 42.7% |
| 2013 | 8.2% | -1.2% | 6.4% | 5.9% | 5.0% | -6.1% | 17.6% | -2.7% | 8.4% | -7.9% | 9.7% | -0.2% | 43.0% |
| 2012 | 15.4% | 0.3% | 4.7% | 1.1% | -1.1% | 10.0% | 1.6% | -1.5% | 5.5% | -10.3% | 6.0% | -0.9% | 30.9% |
| 2011 | -2.0% | 1.2% | 6.7% | 10.5% | 2.0% | -2.8% | -2.7% | -11.2% | -5.8% | 11.1% | -1.3% | 1.7% | 7.4% |
| 37.9% | 16.2% | -5.8% | 3.5% | 26.3% | 64.3% | 24.6% | -1.7% | -17.6% | -22.0% | 68.1% | -9.9% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0.04 | 0.04 | |||||||||||
| 2020 | 0.02 | 0.09 | 0.18 | 0.28 | |||||||||
| 2019 | 0.00 | 0.00 | |||||||||||
| 2018 | 0.06 | 0.06 | 0.07 | 0.01 | 0.20 | ||||||||
| 2017 | 0.02 | 0.11 | 0.04 | 0.04 | 0.20 | ||||||||
| 2016 | 0.06 | 0.05 | 0.03 | 0.02 | 0.15 | ||||||||
| 2015 | 0.08 | 0.15 | 0.05 | 0.15 | 0.43 | ||||||||
| 2014 | 0.11 | 0.21 | 0.19 | 0.16 | 0.67 | ||||||||
| 2013 | 0.01 | 0.02 | 0.03 | 0.01 | 0.07 | ||||||||
| 2012 | 0.07 | 0.07 | |||||||||||
| 0.00 | 0.00 | 0.38 | 0.00 | 0.00 | 0.60 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 | 0.63 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Chemocentryx, Inc. | 1.69% |
| Ocugen Inc | 1.11% |
| Acceleron Pharma Inc | 0.99% |
| Global Blood Therapeutics Inc | 0.98% |
| bluebird bio, Inc. | 0.97% |
| Kodiak Sciences, Inc. | 0.92% |
| Cytokinetics, Incorporated | 0.92% |
| Seagen, Inc. | 0.89% |
| Karuna Therapeutics, Inc. | 0.89% |
| Dynavax Technologies Corporation | 0.88% |
| Avid Bioservices, Inc. | 0.87% |
| Blueprint Medicines Corp. | 0.87% |
| Mirati Therapeutics Inc. | 0.86% |
| ACADIA Pharmaceuticals Inc. | 0.85% |
| Iovance Biotherapeutics Inc | 0.84% |
| Top 15 Weights | 14.53% |
Compare with similar ETFs
| XBI | FXH | GNOM | IHF | IYH | VHT | |
|---|---|---|---|---|---|---|
| Product name | SPDR S&P Biotech ETF | First Trust Health Care AlphaDEX Fund | Global X Genomics & Biotechnology ETF | iShares U.S. Healthcare Providers ETF | iShares U.S. Healthcare ETF | Vanguard Health Care ETF |
| Issuer | SPDR | First Trust | Global X | iShares | iShares | Vanguard |
| Price | $76.72 | $98.3862 | $12.1069 | $260.63 | $257.69 | $226.91 |
| Expense Ratio | 0.35% |  0.61% | 0.5% | 0.42% | 0.43% |  0.1% |
| Average Spread | 0.039% | 0.091% | 0.330% | 0.077% | 0.058% | 0.044% |
| AUM | $4,235,320,000 | $1,282,640,000 | $148,703,000 | $1,180,690,000 | $2,693,670,000 | $14,646,500,000 |
| Shares | 55,204,877 | 13,036,782 | 12,282,460 | 4,530,123 | 10,453,130 | 64,547,526 |
| Average Daily Volume | 11,331,733 | 47,586 | 88,586 | 37,000 | 59,750 | 221,097 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2006-01-31 | 2007-05-08 | 2019-04-05 | 2006-05-01 | 2000-06-12 | 2004-01-26 |
| Index Tracked | S&P Biotechnology Select Industry Index | StrataQuant Health Care Index | Solactive Genomics Index | DJ US Select / Health Care Providers | N/A | MSCI US Investable Market Health Care 25/50 Index |
| Category | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities | Health & Biotech Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Mid/Small Caps | Large/Mid Caps | Large/Mid Caps | Large/Mid Caps | Large Caps | Large Caps |
| Value or Growth | Growth | Growth | Growth | Blend | Growth | Growth |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | U.S. | U.S. | U.S. | U.S. | U.S. | U.S. |
| Annual Dividend Rate | $0 | $0.101 | $0.007 | $1.625 | $3.089 | $3.134 |
| Annual Dividend Yield | 0.000% | 0.001% | 0.001% | 0.006% | 0.012% | 0.014% |
| Number of Holdings | 196 | 88 | 40 | 62 | 127 | 451 |
| YTD Return | -31.48% | -20.68% | -39.01% | -9.79% | -13.47% | -13.98% |
| Beta | 1.42 | 0.93 | 0.90 | 1.09 | 0.89 | 0.88 |
| Upside Beta | 0.12 | 0.07 | 0.11 | 0.16 | 0.25 | 0.20 |
| Downside Beta | -0.15 | -0.09 | -0.27 | -0.12 | 0.14 | 0.08 |
| Volatility 1Y | 45.75% | 20.98% | 45.00% | 21.56% | 18.63% | 19.10% |
| Sharpe Ratio 3Y | -0.12 | 0.65 | -0.15 | 1.08 | 0.91 | 0.88 |
| Treynor Ratio 3Y | 0.00 | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 |